BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36227588)

  • 41. A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years.
    Bailey SL; Sigal BM; Plevritis SK
    J Natl Cancer Inst; 2010 Aug; 102(16):1263-71. PubMed ID: 20664027
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breast cancer early diagnosis experience in Florence: can a self referral policy achieve the results of service screening?
    Giorgi D; Paci E; Zappa M; Rosselli del Turco M
    J Epidemiol Community Health; 1994 Oct; 48(5):471-5. PubMed ID: 7964357
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Estimated mammogram coverage in Goiás State, Brazil].
    Corrêa Rda S; Freitas-Júnior R; Peixoto JE; Rodrigues DC; Lemos ME; Marins LA; Silveira EA
    Cad Saude Publica; 2011 Sep; 27(9):1757-67. PubMed ID: 21986603
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Annual mammography screening: is it necessary?
    Hegar V; Oliveira K; Kakarala B; Mangram A; Dunn E
    Am Surg; 2012 Jan; 78(1):104-6. PubMed ID: 22273325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mammographic Screening of Women Attending a Reference Service Center in Southern Brazil.
    Romeiro Lopes TC; Franca Gravena AA; Demitto Mde O; Brischiliari SC; Borghesan DH; Dell Agnolo CM; Carvalho MD; Pelloso SM
    Asian Pac J Cancer Prev; 2016; 17(3):1385-91. PubMed ID: 27039777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. International variation in screening mammography interpretations in community-based programs.
    Elmore JG; Nakano CY; Koepsell TD; Desnick LM; D'Orsi CJ; Ransohoff DF
    J Natl Cancer Inst; 2003 Sep; 95(18):1384-93. PubMed ID: 13130114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Longitudinal trends in mammographic percent density and breast cancer risk.
    Vachon CM; Pankratz VS; Scott CG; Maloney SD; Ghosh K; Brandt KR; Milanese T; Carston MJ; Sellers TA
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):921-8. PubMed ID: 17507617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival of patients with operable breast cancer (Stages I-III) at a Brazilian public hospital--a closer look into cause-specific mortality.
    Balabram D; Turra CM; Gobbi H
    BMC Cancer; 2013 Sep; 13():434. PubMed ID: 24063763
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age-based versus Risk-based Mammography Screening in Women 40-49 Years Old: A Cross-sectional Study.
    Burnside ES; Trentham-Dietz A; Shafer CM; Hampton JM; Alagoz O; Cox JR; Mischo E; Schrager SB; Wilke LG
    Radiology; 2019 Aug; 292(2):321-328. PubMed ID: 31184557
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical outcomes of mammography in the National Breast and Cervical Cancer Early Detection Program, 2009-2012.
    White A; Miller J; Royalty J; Ryerson AB; Benard V; Helsel W; Kammerer W
    Cancer Causes Control; 2015 May; 26(5):723-32. PubMed ID: 25809209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changing emphasis in breast diagnosis: the surgeon's role in evaluating mammographic abnormalities.
    Sterns EE
    J Am Coll Surg; 1997 Mar; 184(3):297-302. PubMed ID: 9060928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Access to early breast cancer diagnosis in the Brazilian Unified National Health System: an analysis of data from the Health Information System].
    Azevedo E Silva G; Bustamante-Teixeira MT; Aquino EM; Tomazelli JG; Dos-Santos-Silva I
    Cad Saude Publica; 2014 Jul; 30(7):1537-50. PubMed ID: 25166949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Costs of mammogram campaigns in the Regional Health Division of Marília, São Paulo State, Brazil, 2005-2006].
    Marconato RR; Soárez PC; Ciconelli RM
    Cad Saude Publica; 2011 Aug; 27(8):1529-36. PubMed ID: 21877001
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Frequency and predictive value of a mammographic recommendation for short-interval follow-up.
    Yasmeen S; Romano PS; Pettinger M; Chlebowski RT; Robbins JA; Lane DS; Hendrix SL
    J Natl Cancer Inst; 2003 Mar; 95(6):429-36. PubMed ID: 12644536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nationwide cross-sectional adherence to mammography screening guidelines: national behavioral risk factor surveillance system survey results.
    Narayan A; Fischer A; Zhang Z; Woods R; Morris E; Harvey S
    Breast Cancer Res Treat; 2017 Aug; 164(3):719-725. PubMed ID: 28508184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Difficulties in implementing an organized screening program for breast cancer in Brazil with emphasis on diagnostic methods.
    Silva TB; Mauad EC; Carvalho AL; Jacobs LA; Shulman LN
    Rural Remote Health; 2013; 13(2):2321. PubMed ID: 23597169
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Training Community Health Workers to promote breast cancer screening in Brazil.
    Bittencourt L; Scarinci IC
    Health Promot Int; 2019 Feb; 34(1):95-101. PubMed ID: 29036489
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mammography Coverage and Tumor Stage in the Opportunistic Screening Context.
    Magario MB; Poli-Neto OB; Tiezzi DG; Angotti Carrara HH; Moreira de Andrade J; Candido Dos Reis FJ
    Clin Breast Cancer; 2019 Dec; 19(6):456-459. PubMed ID: 31133460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Downstaging in opportunistic breast cancer screening in Brazil: a temporal trend analysis.
    Vale DB; Filho CC; Shinzato JY; Spreafico FS; Basu P; Zeferino LC
    BMC Cancer; 2019 May; 19(1):432. PubMed ID: 31077162
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mammographic screening in women at increased risk of breast cancer after treatment of Hodgkin's disease.
    Kwong A; Hancock SL; Bloom JR; Pal S; Birdwell RL; Mariscal C; Ikeda DM
    Breast J; 2008; 14(1):39-48. PubMed ID: 18186864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.